(Updated - February 24, 2025 7:14 AM EST)

Oppenheimer analyst Leland Gershell upgraded BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE